Correction to “Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine”
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Correction to “Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine” ; day:24 ; month:01 ; year:2025 ; extent:1
Advanced science ; (24.01.2025) (gesamt 1)
- DOI
-
10.1002/advs.202414927
- URN
-
urn:nbn:de:101:1-2501251308497.014703623410
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Ähnliche Objekte (12)
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform
Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
TH9 cells in anti-tumor immunity
Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine
Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform
Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
TH9 cells in anti-tumor immunity
Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine
Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform
Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
TH9 cells in anti-tumor immunity
Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine
Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma